Brain zap and pill combo tested to rekindle motivation in dementia
NCT ID NCT07279740
Summary
This study is testing whether a two-part treatment can help reduce apathy, a common loss of motivation, in people with Alzheimer's disease. Researchers are combining a stimulant medication (methylphenidate) with a gentle, non-invasive brain stimulation technique. The goal is to see if this combination is safe and more effective at improving motivation and engagement than current options.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER'S DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Sunnybrook Research Institute
RECRUITINGToronto, Ontario, M4N 3M5, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.